Theranos

Blood testing and early disease detection services.

Launch date

Jan 2003–Sep 2018

Employees

Market cap

Enterprise valuation

€1 (Public information from Sep 2018)

Palo Alto California (HQ)

Date	Investors	Amount	Round
Jun 2004	Threshold Ventures	$500k	Seed
Feb 2005	Rupert Murdoch	$5.8m	Series A
Feb 2006	ATA Ventures	$9.1m	Series B
Nov 2006	ATA Ventures Tako Ventures Continental Properties The Lawrence J. Ellison Revocable Trust	$28.5m	Series C
Jul 2010	N/A	$45.0m	Late VC
Sep 2013	Walgreen	$50.0m	Late VC
Feb 2014	N/A	$199m	Growth Equity VC
Jun 2014	N/A	N/A Valuation: $9.0b	Late VC
Mar 2015	Jupiter Partners B.J. Cassin PFM Health Sciences Raymond Bingham The Blue Venture Fund Continental Properties Palmieri Family Trust Esoom Enterprise	$349m	Growth Equity VC
May 2017	Puget Sound Venture Club	$582m	Secondary
Dec 2017*	Fortress Investment Group & 1 more	$100m	Debt
Sep 2018*	N/A	N/A	Bankruptcy
Total Funding		€624m

Tech stackLearn more about the technologies and tools that this company uses.

Recent News about Theranos